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Highlights 
 T.cruzi infection is endemic in the Bolivian Chaco 
 Childhood T.cruzi seroprevalence was 0.22, rising steeply with age 
 Persistent transmission persists shown by FOI annual incidence estimate of 0.021 
 School-based screening with rapid tests is a practical approach in remote areas 
 Current intermittent vector control practises in the Bolivian Chaco are suboptimal 
 
Abstract 
Background 
We screened for Trypanosoma cruzi infection amongst children in a rural community in the 
Bolivian Chaco, an area known for high prevalence. We also estimated the force of infection (FOI). 
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Methods 
423 children were screened using InBios (Seattle, WA) ChagasDetectPlus (CDP) rapid test at the 
local school.  CDP-positive specimens were further tested by indirect hemagglutination assay 
(IHA) and Wiener Recombinante v3.0 ELISA. A catalytic model was used to estimate FOI. 
Results 
Confirmed seroprevalence was 0.22, rising steeply with age. The mean age of seropositive 
individuals was 13 years. Rapid test specificity was calculated 91.9%, the annual incidence 
estimated from the FOI was 0.021. 
Conclusion 
This study demonstrates persistent transmission and continued high levels of T.cruzi infection in 
the Bolivian Chaco, and highlights the practicality of school-based screening. 
 
Keywords: Chagas; Trypanosoma cruzi; Bolivian Chaco 
 
Introduction 
The semi-arid lowland of the Gran Chaco spanning parts of Bolivia, Paraguay and Argentina is 
reported to have the highest prevalence of T.cruzi infection in the world, due to well documented 
local challenges in triatomine vector control and surveillance (Gurtler, 2009, World Health 
Organisation, 2015)   Chronic infection with T. cruzi, the aetiological agent of Chagas disease, leads 
to clinically significant cardiovascular and gastrointestinal disease in an estimated 30-40% of 
cases, and treatment remains challenging (Perez-Molina and Molina, 2018). Untreated, infection 
persists lifelong, and thus prevalence increases with age, reflecting cumulative incidence.  
Children are often tested as a sentinel population for recent transmission, with effective vector 
control rapidly decreasing seroprevalence in this subpopulation. Despite this, published 
childhood seroprevalence data from the Bolivian Chaco are limited; to date, few seroscreening 
studies have been published, with the most recent reporting a seroprevalence of 19.8% (Samuels 
et al., 2013). Here, we report the results of a recent screening study, demonstrating persistent 
high levels of infection indicating sustained vector transmission. 
 
Methods 
Screening 
At the request of the local authorities, we screened school-age children in July to August 2017 in 
a village near Camiri, the capital of Cordillera province in the Bolivian Chaco. All children 
attending the local primary and secondary schools were eligible to participate, with no age 
restriction.  The child’s parent or guardian provided written informed consent, and verbal assent 
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was obtained from the child. Children were screened using the ChagasDetectPlus (CDP) 
immunochromatographic assay (InBios, Seattle, WA), previously shown to have 96.2% sensitivity 
and 98.8% specificity in a similar population in the Bolivian Chaco (Shah et al., 2014).  Children 
with positive CDP results had venous blood drawn and tested by the indirect haemagglutination 
assay (IHA; Chagas Polychaco kit; Lemos Laboratories, Buenos Aires, Argentina) following 
national Chagas disease control protocols.  Discordant specimens were further tested by Wiener 
Recombinante v3 ELISA. 
 
Seropositive individuals were offered benznidazole treatment in accordance with local 
governmental protocols. The houses of infected children were sprayed by the local control 
program before commencement of treatment. 
 
Analysis 
Descriptive statistics were generated using IBM SPSS v24. The force of infection (FOI) was 
calculated using a catalytic model applied to age-prevalence data (Courtenay et al., 1994).  
Ethical approval was granted by The University of Warwick’s Biomedical & Scientific Research 
Ethics Committee (BSREC) Committee. 
 
 
Results 
A total of 424 children were eligible for screening, and 423 were tested by CDP in capillary 
fingerstick blood. The mean age of tested children was 11 (SD 4.4, range 4-21); 49.1% were male. 
CDP results were positive for 122 individuals. One child with positive CDP refused IHA testing.  
One child reported a previous positive result by IHA but tested negative by CDP, and was included 
in IHA testing.  Of 121 children tested by IHA, 94 had positive results: 93 with positive CDP results 
plus the previously IHA-positive CDP-negative student.  The 29 sera with discordant results were 
all negative by ELISA.   These results correspond to CDP specificity of 91.9% (exact 95% 
confidence interval 88.6 – 94.5).  The final seroprevalence was 0.22 (95% CI=18.4-26.2; 93/422, 
excluding the unconfirmed positive CDP result from the analysis). 
The mean age of seropositive individuals was 13 (SD 3.9, range 5-21); 47.3% were male.  As 
expected, prevalence increased steeply with age.  
The age-prevalence increased with age with no apparent recovery, as shown in Figure 1. The 
annual incidence estimated from the FOI was 0.021 (95% CI=0.0128-0.0294). 
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Discussion 
The observed seroprevalence is similar to that previously described by Samuels et al in 2013 (age 
< 16 = 18.9% and 19.8% respectively) in a nearby municipality. This, coupled with the high FOI 
estimate, demonstrates significant recent vector transmission.  Although the ChagasDetectPlus 
specificity (91.9%) in this study was lower than in previous analyses, screening in this rural 
village was greatly facilitated by the use of this rapid test (Eguez et al., 2017, Shah et al., 2014).  
Pairing a highly sensitive rapid test with a more specific confirmatory test allows efficient 
screening, even in a challenging community setting. Practicality was further enhanced by our 
school-based screening model, which provided an accurate record of potential participants 
without reliance on census data, and facilitated timely testing. 
 
Poor treatment compliance with the 60-day treatment course and frequent adverse drug 
reactions have made screen-and-treat programmes hard to justify in a healthcare system with 
limited resources.  Recent results from the BENDITA Phase II trial (Drugs for Neglected Diseases 
Initiative, 2019) suggest that shorter courses of benznidazole may provide equivalent 
parasitological efficacy to the current 60-day standard course.  If Phase III trials confirm these 
results, large scale paediatric screen-and-treat programmes may become feasible in resource 
poor settings. We advocate school-based screening with rapid tests as a practical way to achieve 
this, at least in areas such as the study community where school attendance is high.   In 
communities where a significant proportion of children do not attend school, school-based 
designs may miss high risk children.   
 
Our results add weight to the current consensus that significant vector transmission persists, and 
that the current intermittent vector control practises in the Bolivian Chaco are suboptimal, but 
critical to improve. 
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Figure 1 – Comparison of FOI catalytic model and observed seroprevalence  
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Table 1 – Comparison of seropositive and seronegative individuals by age range 
 
Age group Total tested  Positive (%) 
4-6 89 5 (5.6) 
7-10 98 22 (22.4) 
11-14 115 28 (24.3) 
15+ 120 38 (31.7) 
Total 422 93 (22.0) 
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